ClinicalTrials.gg
Not yet recruitingNCT07877402DLSUpdated Oct 16, 2026

Treating Seasonal Depression With Daylight

An interventional study of Outdoor and Indoor in Depression, sponsored by Klaus Martiny. Not yet recruiting at 2 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Klaus Martiny · Not applicable, Interventional, and Treatment

Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A seasonal pattern in the on- and offset of depressive episodes in recurrent depressive disorder is prevalent at latitudes with large summer-winter differences in daylength. In Denmark we estimate that 10-12% of the population experience winter depression symptoms with functional impairment, and 1-2% of the population is expected to fulfil the ICD-11 criteria for a recurrent depression episode with a winter seasonal pattern (seasonal depression). First-line treatment of seasonal depression is light delivered by a light box with exposure for ½-1 hour each morning in the season. Based on the physical characteristics and physiological responses daylight should be just as effective as light from a light box. Therefore, in this study the aim is to investigate whether 30 minutes daily outside walks for 6 weeks has an antidepressant effect.

Read the detailed description

Methods and analyses The study will include 150 patients, during the winter seasons, fulfilling the ICD-11 diagnostic criteria for seasonal depression, winter type and not spending more than 2 hours outside in the last month. Patients will be randomly allocated to either a 30 minutes' daily walk outdoors or 30 minutes daily reading books or listening to podcast. Any actual depression treatment will continue. All patients will be followed for 6 weeks and will wear a CamNtech MotionWatch 8 device to assess 24-hour activity and light exposure. The primary outcome is the estimated difference between groups on the SIGH-SAD-SA self-assessment scale using all data from the 6 weeks assessments. The association between actigraphy data, light sensor data, self-reported sleep measures, and depression outcomes will also be also investigated.

02

Conditions studied

  • Depression

Browse trials for

Keywords

  • Daylight
  • Reading
  • Depression
  • Sleep
  • Circadian
03

In context

Depression

8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 150 is above the median of 84 across 6,869 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Klaus Martiny is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Seasonal depression according to ICD-11

Exclusion criteria

Exclusion Criteria:

Bipolar and psychotic disorder Working outside more than 2 hours a day

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Outdoor

    Daylight exposure

    Other: Outdoor

  • Active comparator
    Indoor

    Reading

    Other: Indoor

Interventions

  • OtherOutdoor

    Exposure to 30 minutes of Daylight

  • OtherIndoor

    Reading for 30 minutes indoor

06

What researchers measure

Primary outcomes

  1. Structured Interview Guide for the Hamilton Depression Rating Scale - Seasonal Affective Disorder Self assessment version (SIGH-SAD-SA)

    Selfrating instrument to assess depression with atypical symptoms. Score range from 0-77, 77= worst depression

    Time frame: Used weekly with a 1 week recall

  2. Sleep onset latency

    Time falling a sleep based on a the sleep diary

    Time frame: Daily ratings throughout the whole 6 week study period

Other outcomes

  1. WHO-5 quality of life

    Quality of life scale. Score range from 0-100, 100= best quality of life

    Time frame: Used weekly with a 1 week recall

07

Study locations

2 sites
  • Psykiatriens hus
    Aarhus, 8000, Denmark
  • Frederiksberg Bispebjerg Hospital
    Frederiksberg, 2000, Denmark
08

References and documents

Individual participant data

Plan to share: Undecided — On reasonal request

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07877402
Lead sponsor
Klaus Martiny
Responsible party
Klaus Martiny (Professor, University Hospital Bispebjerg and Frederiksberg) — Sponsor-investigator
First posted
Oct 16, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Dec 1, 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
Oct 16, 2026

Study contacts

Klaus Martiny, Professor
Contact
klaus.martiny@regionh.dk
24991536

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion